|
PDCD11 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.125600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.776600E-01 |
| Normal-vs-Stage2 |
2.596200E-02 |
| Normal-vs-Stage3 |
2.895400E-03 |
| Normal-vs-Stage4 |
6.736400E-02 |
| Stage1-vs-Stage2 |
5.760100E-02 |
| Stage1-vs-Stage3 |
2.661900E-03 |
| Stage1-vs-Stage4 |
1.637230E-01 |
| Stage2-vs-Stage3 |
7.583200E-01 |
| Stage2-vs-Stage4 |
5.597800E-01 |
| Stage3-vs-Stage4 |
2.852200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.868100E-02 |
| Normal-vs-AfricanAmerican |
5.361400E-01 |
| Normal-vs-Asian |
3.880600E-01 |
| Caucasian-vs-AfricanAmerican |
2.408000E-01 |
| Caucasian-vs-Asian |
1.124360E-01 |
| AfricanAmerican-vs-Asian |
3.214200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.385840E-02 |
| Normal-vs-Female |
4.612800E-01 |
| Male-vs-Female |
1.033850E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.626000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.491500E-02 |
| Normal-vs-Age(61-80Yrs) |
7.367800E-02 |
| Normal-vs-Age(81-100Yrs) |
3.057500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.519000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.140400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.648300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.811000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.098500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.352300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.809800E-01 |
| Normal-vs-Grade 2 |
2.571400E-01 |
| Normal-vs-Grade 3 |
5.700200E-03 |
| Normal-vs-Grade 4 |
9.396100E-02 |
| Grade 1-vs-Grade 2 |
7.361900E-02 |
| Grade 1-vs-Grade 3 |
7.299800E-03 |
| Grade 1-vs-Grade 4 |
4.112300E-02 |
| Grade 2-vs-Grade 3 |
2.947800E-02 |
| Grade 2-vs-Grade 4 |
3.695600E-01 |
| Grade 3-vs-Grade 4 |
5.235400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.985600E-01 |
| Normal-vs-ccB subtype |
3.661800E-02 |
| ccA subtype-vs-ccB subtype |
2.487400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.136100E-02 |
| Normal-vs-N1 |
7.334000E-01 |
| N0-vs-N1 |
1.685810E-01 |
|
|
